Reduced volume formulation of glatiramer acetate and methods of administration
US9018170B2 · kind B2 · utility
12Cited by
15References
6Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Nov 17, 2010 |
| Grant date | Apr 28, 2015 |
| Priority date | — |
| Expiry date | Feb 1, 2034 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P37/02
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A method for reducing frequency of relapses in a human patient afflicted with relapsing-remitting multiple sclerosis (RRMS) comprising administering to the patient 0.5 ml of an aqueous pharmaceutical solution of 20 mg glatiramer acetate and 20 mg mannitol.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.